Nirmish Singla, MD, MSc

• Director of Translational Research in GU Oncology
• Director, Kidney Cancer Program
• Co-Director, Upper Tract Urothelial Cancer (UTUC) Program
• Vice Chair for Quality, Safety, & Service, Brady Urological Institute

Dr. Nirmish Singla is a Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins University, where he serves as the Director of Translational Research in Genitourinary Oncology. He is also the Director of the Kidney Cancer Program and co-directs the Upper Tract Urothelial Cancer (UTUC) Program.  He represents the Sidney Kimmel Comprehensive Cancer Center (SKCCC) on the National Comprehensive Cancer Network (NCCN) Testicular Cancer Guidelines Panel and helps lead the Testicular Cancer Program.  He helped create several multidisciplinary clinics (MDCs) in urologic oncology at Johns Hopkins, including the UTUC MDC, kidney cancer MDC, and testicular cancer MDC.  He serves the Brady in a leadership capacity as Vice Chair for Quality, Safety, & Service; Physician Advisor; Faculty Senator for the Department of Urology; and Editor-in-Chief of the Brady's flagship annual publication, Discovery.  He established and chairs the Brady Morbidity & Mortality Committee.  He serves as Core Faculty for the Hopkins Business of Health Initiative (HBHI), Affiliate Faculty for the Armstrong Institute for Patient Safety and Quality, and Affiliate Faculty for the Malone Center for Engineering in Healthcare.  He was also recognized for his academic contributions internationally as an Adjunct Professor within the Department of Urology and Comprehensive Cancer Center at the Medical University of Vienna in Austria.

Dr. Singla received his undergraduate degree (B.S.E.) in Biomedical Engineering from the University of Michigan and his medical degree (M.D.) from the University of Michigan Medical School, where he was supported by a full-tuition Dean’s Merit Scholarship. He went on to complete his residency training in Urologic Surgery at the University of Texas Southwestern Medical Center (UTSW).  Following his residency, he received an NIH/NCI Ruth L. Kirschstein National Research Service Award T32 grant and spent an additional year at UTSW as a postdoctoral research fellow in Urologic Oncology with a specialized translational focus in kidney cancer through the Physician Scientist Training Program. During this time, he earned a Master of Science in Clinical Science (M.S.C.S.) degree through the Center for Translational Medicine at UTSW and helped develop and pioneer a Physician Administrative Fellowship program. He then completed an advanced surgical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York through the Society of Urologic Oncology (SUO) before joining the faculty at Johns Hopkins, where he is pursuing an M.B.A. through the Carey Business School.

Dr. Singla’s clinical practice spans the complete spectrum of genitourinary oncology, including adrenal, kidney, upper tract, bladder, prostate, penile, urethral, and testicular cancers. His surgical approaches include mastery of both open and minimally-invasive (endoscopic, laparoscopic, and robotic) techniques. Dr. Singla provides personalized and compassionate care for patients affected by urologic cancer by integrating cutting-edge technologies and multidisciplinary approaches to treatment.

As both a surgeon-scientist and clinical trialist, Dr. Singla’s overarching goal is to help scientific discoveries in the laboratory materialize for patients with urologic cancers in the clinic. He runs a well-funded, multidisciplinary, translational laboratory specializing in urologic oncology. Dr. Singla has co-authored over 350 articles and textbook chapters, and he has developed an international reputation as a thought leader in urologic oncology. He has secured a substantial amount of research funding and serves as the lead PI on multiple grants from federal, foundational, intramural, and private sources across various GU malignancies.

• Armstrong Institute for Patient Safety and Quality
• Bloomberg~Kimmel Institute for Cancer Immunotherapy
• Brady Urological Institute
• Comprehensive Adrenal Center
• Hopkins Business of Health Initiative
• Johns Hopkins Greenberg Bladder Cancer Institute
• Malone Center for Engineering in Healthcare
• Robotic and Minimally Invasive Surgery
• Sidney Kimmel Comprehensive Cancer Center
• The Johns Hopkins Precision Medicine Center of Excellence for Prostate Cancer
• Von Hippel-Lindau Clinical Care Center

View all trials by this principal investigator.

• Nirmish Singla, M.D., M.Sc. | Urologic Oncologist

• Johns Hopkins Brady Urological Institute's Kidney Cancer Program

• Kidney Cancer FAQ

• Testicular Cancer Q&A

• Johns Hopkins Brady Urological Institute's Testicular Cancer Program

• JHGBCI Virtual Grand Rounds | It's All Related: Kidney Health for Bladder Cancer Patients

• JHGBCI Virtual Grand Rounds | Upper Tract Urothelial Cancer: It's a Team Effort

Learn more about the Singla Research Program: Clinical and Translational Research in Genitourinary Oncology

• President's Award, Indian American Urological Association (IAUA) (2026)
• Baltimore Magazine's Top Doctors (2025)
• Dean's Scholarship (M.B.A. program), Johns Hopkins Carey Business School (2025-)
• Alpha Omega Alpha (AOA) Honor Medical Society (Inducted 2025)
• Adjunct Professor, Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Austria (2025-)
• American Urological Association (AUA) / Japanese Urological Association (AUA) Academic Exchange Program (2024)
• Fellow of the American College of Surgeons (Inducted 2023)
• Society of Urologic Oncology (SUO) - European Association of Urology (EAU) Exchange Program Scholarship (2023)
• The Carolyn and Bill Stutt Scholar, Patrick C. Walsh Prostate Cancer Research Award (2022-2024)
• American Urological Association (AUA) Urology Care Foundation Research Scholar Award (2022-2024)
• Kidney Cancer Association (KCA) Young Investigator Award (YIA) (2021-2022)
• American Association for the Advancement of Science (AAAS)/Science Program for Excellence in Science (2020)
• National Institutes of Health/National Cancer Institute (NIH/NCI) Ruth L. Kirschstein National Research Service Award (T32 Physician Scientist Oncology Training Program Research Grant) (2018-2019)
• Rising Star in Oncology, Society for Translational Oncology Fellows' Forum (STOFF) (2018)
• John Quale Travel Fellowship Award, Bladder Cancer Advocacy Network (BCAN) Bladder Cancer Think Tank (2018)
• Dean's Award for Graduation with Distinction in (1) Research, (2) Medical Education, and (3) Service, University of Michigan Medical School (2013)
• Full-Tuition Dean's Merit Scholarship, University of Michigan Medical School (2009-2013)

• American Urological Association (AUA)
• Society of Urologic Oncology (SUO),Young Urologic Oncologists Section (YUO), SUO-Clinical Trials Consortium (CTC)
• American Society of Clinical Oncology (ASCO)
• American Association for Cancer Research (AACR)
• Kidney Cancer Association (KCA)
• American Association for the Advancement of Science (AAAS)
• Société Internationale d'Urologie (SIU)
• Alpha Omega Alpha (AOA) Honor Medical Society
• American Medical Association (AMA)
• Indian American Urological Association (IAUA)
• American Association of Clinical Urologists (AACU)
• University of Michigan Department of Urology Reed Nesbit Society
• International Young Urological Association (IYUA)
• Association for Academic Surgery (AAS)
• American College of Surgeons